Recent Finacing
Recent Raise
Endlyz is a London-based biotech developing small-molecule programs that target endo-lysosomal pathways (notably ATP13A2 and ATP10B) to address neurodegenerative disease mechanisms.
Focus Areas
Recent Investors
Funding round
